References
- Enig B, Petersen HN, Smith DF, Larsen B. Food preferences, nutrient intake and nutritional status in cancer patients. Acta Oncol 1987; 26: 301–5
- De Wys WD. Pathophysiology of cancer cachexia: Current understanding and areas for future research. Cancer Res 1982; 42(Suppl 2)721s–726
- Glicksman AS, Rawson RW. Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 1956; 9: 1127–34
- Roh MS, Ekman L, Jeevanandam M, Brennan MF. Gluconeogenesis in tumor influenced hepatocyte. Surgery 1984; 96: 427–34
- Yoshikawa T, Noguchi Y, Matsumoto A. Effects of tumor removal and body weight loss on insulin resistance in patients with cancer. Surgery 1994; 116: 62–6
- Carmichael MJ, Clague MB, Keir MJ, Johnston ID. Whole body protein turnover, synthesis and breakdown in patients with colorectal carcinoma. Br J Surg 1980; 67: 736–9
- Lundholm K, Edstorm S, Ekman L, Bylund AC, Schersten T. A comparative study of the influence of malignant tumor on host metabolism in mice and man: Evaluation of an experimentalmodel. Cancer 1978; 42: 453–61
- De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifing insulin secretion and insulin resistance. Am J Physiol 1979; 237: E214–223
- Luzi L, Secchi A., Facchini F, Battezzati A, Staudacher C, Spotti D, et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 1990; 33: 549–56
- Steele R. Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 1959; 82: 420–30
- Heber D, Tchekmedyian NS. Pathophysiology of cancer: Hormonal and metabolic abnormalities. Oncology 1992; 49(Suppl 2)28–31
- Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi Fanelli F. Prevention and treatment of cancer cachexia: New insights into an old problem. Eur J Cancer 2006; 42: 31–41
- Reda E, D'Iddio S, Nicolai R, Benfatti P, Calvani M. The carnitine system and body composition. Acta Diabetol 2003; 40(Suppl 1)S106–13